Get started
Author

Syed Numan

Observed names: Numan S, Numan, Syed, S Numan, SYED NUMAN
OpenAlex ID: A5024989397
Non-medical Switching from Originator Tumor Necrosis Factor Inhibitors to Their Biosimilars: Systematic Review of Randomized Controlled Trials and Real-World Studies
2018 · Syed Numan, Freddy Faccin · Advances in Therapy · 36
PDF
Frequency and Associated Costs of Anaphylaxis- and Hypersensitivity-Related Adverse Events for Intravenous Iron Products in the USA: An Analysis Using the US Food and Drug Administration Adverse Event Reporting System
2020 · Henry Trumbo, Karolina Kaluza, et al. · Drug Safety · 32
PDF
Systematic review of guidelines for the diagnosis and treatment of iron deficiency anemia using intravenous iron across multiple indications
2020 · Syed Numan, Karolina Kaluza · Current Medical Research and Opinion · 24
Characterization of Serum Phosphate Levels Over Time with Intravenous Ferric Carboxymaltose Versus Placebo as Treatment for Heart Failure with Reduced Ejection Fraction and Iron Deficiency: An Exploratory Prospective Substudy From HEART-FID
2024 · Nina Nouhravesh, Jyotsna Garg, et al. · European Journal of Heart Failure · 6
PDF
Prediction and Longer-Term Outcomes of All-cause and Cardiovascular Mortality in the HEART-FID Trial
2025 · JUSTIN A. EZEKOWITZ, HILLARY MULDER, et al. · Journal of Cardiac Failure · 4
PDF
Patient-Reported Outcomes After Ferric Carboxymaltose Treatment for Iron Deficiency Anemia: A Prospective Observational Study
2023 · Winghan J Kwong, Syed Numan, et al. · International Journal of General Medicine · 1
PDF
Frequency and Medical Costs of Hypersensitivity- and Anaphylaxis-Related Adverse Events for Different Intravenous Iron Products Using the US Food and Drug Administration Adverse Event Reporting System (FAERS)
2026 · Ye Wang, Syed Numan · medRxiv
EE304 Healthcare Resource Utilization and Cost of Care of Different IV Iron Treatments in Heart Failure Patients Diagnosed With Iron Deficiency/Iron Deficiency Anemia Using a Real-World Database
2024 · Y Wang, J Beebe, et al. · Value in Health
PDF
All-cause Mortality in the Heart-fid Trial
2024 · Justin A. Ezekowitz, Hillary Mulder, et al. · Journal of the American College of Cardiology
PDF
Serum Phosphate Levels Over Time With Intravenous Ferric Carboxymaltose as Treatment for Heart Failure With Reduction Ejection Fraction and Iron Deficiency: a Prospective Substudy From Heart-fid
2024 · Nina Nouhravesh, Jyotsna Garg, et al. · Journal of the American College of Cardiology
Comparison of Healthcare Resource Utilization, Cost of Care, and Health Outcomes Associated with Different Intravenous Iron Products in Heart Failure Patients with Iron Deficiency/Iron Deficiency Anemia: A Claims Database Analysis
2024 · Ye Wang, Jacob Beebe, et al. · Journal of Clinical Haematology
PDF
Patient Reported Outcomes after Ferric Carboxymaltose Treatment for Iron Deficiency Anemia: A Prospective Observational Study
2022 · Jackie Kwong, Syed Numan, et al. · Blood
Authors’ Reply to Michael Auerbach’s Comment on: “Frequency and Associated Costs of Anaphylaxis- and Hypersensitivity-Related Adverse Events for Intravenous Iron Products in the USA: An Analysis Using the US Food and Drug Administration Adverse Event Reporting System”
2021 · Henry Trumbo, Karolina Kaluza, et al. · Drug Safety
PDF
Non-medical Switching From Originator Tumor Necrosis Factor Inhibitors to Their Biosimilars: Systematic Review of Randomized Controlled Trials and Real-World Studies
2018 · Numan, Syed, Faccin, Freddy · Figshare
Works count: 15
Citation count: 103
H-index: 4
I10-index: 3
Year
Topic
Type